However, as TGFβI has been demonstrated to be abnormally expressed in multiple tumour diseases [10], [11], it is still challenging to achieve an accurate early diagnosis of HCC solely relying on TGFβI. This evidence concerns the gene TGFBI and hepatocellular carcinoma.